{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:08:34Z","timestamp":1778850514267,"version":"3.51.4"},"reference-count":29,"publisher":"Scientific Scholar","content-domain":{"domain":["cytojournal.com"],"crossmark-restriction":true},"short-container-title":["Cytojournal"],"abstract":"\n Objectives:<\/jats:title>\n Sex-determining region Y-box transcription factor 2 ( SOX2) has been implicated in tumorigenesis across various cancers. This study sought to characterize the expression pattern of SOX2 in hepatocellular carcinoma (HCC) and elucidate its potential mechanism in promoting HCC progression by targeting Forkhead box J3 (FOXJ3) and regulating the phosphoinositide 3-kinase\/protein kinase B (PI3K\/AKT) signaling pathway, autophagy, and mitophagy.<\/jats:p>\n <\/jats:sec>\n \n Material and Methods:<\/jats:title>\n SOX2 expression was examined in normal liver epithelial (THLE2) and HCC (Huh7) cells. It was modulated by shRNA-mediated knockdown and plasmid-based overexpression. 5-Ethynyl-2'-deoxyuridine (EdU) fluorescence staining assay, Transwell assays, and flow cytometry were performed to evaluate cell viability and motility. Autophagy and mitophagy were assessed by Western blotting and transmission electron microscopy, and mitochondria-lysosome co-localization was visualized by immunofluorescence staining. The roles of SOX2 and FOXJ3 in the PI3K\/AKT signaling pathway were investigated.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n SOX2 was markedly upregulated in HCC cells (\n P<\/jats:italic>\n <0.001). SOX2 overexpression enhanced the viability and motility of Huh7 cells and inhibited apoptosis, whereas SOX2 knockdown elicited opposite effects (\n P<\/jats:italic>\n <0.001). Mechanistically, SOX2 upregulated autophagy-related proteins Microtubule-Associated Protein 1 Light Chain 3 ( LC3)-II\/LC3-I and p62, promoted autophagosome formation, increased PTEN-induced kinase 1 ( PINK1) and p-COX4 levels, and facilitated mitochondria-lysosome co-localization (\n P<\/jats:italic>\n <0.05). Co-overexpression of FOXJ3 reversed the promotive effects of SOX2 on cell proliferation, migration, autophagy, and mitophagy and attenuated PI3K\/AKT pathway activation (\n P<\/jats:italic>\n <0.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n SOX2 promotes HCC progression by negatively regulating FOXJ3, thereby activating the PI3K\/AKT signaling pathway and inducing autophagy and mitophagy. The potential SOX2-FOXJ3-PI3K\/AKT axis may serve as a novel regulatory pathway underlying HCC development and represents a potential target for therapeutic intervention.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/cytojournal_164_2025","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:21:52Z","timestamp":1778847712000},"page":"28","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SOX2 promotes the progression of hepatocellular carcinoma by targeting FOXJ3 and activating the PI3K\/AKT pathway to regulate autophagy and mitophagy"],"prefix":"10.25259","volume":"23","author":[{"given":"Zhigang","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Shandong Provincial Hospital, Shandong University, Shandong, China,"},{"name":"Department of Infectious Diseases, Binzhou People\u2019s Hospital, Shandong, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanhua","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Shandong Provincial Hospital, Shandong University, Shandong, China,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"10.25259\/Cytojournal_164_2025\/ref-1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","article-title":"Hepatocellular carcinoma: New developments","volume":"27","author":"Ganesan","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.25259\/Cytojournal_164_2025\/ref-2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma: A review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"key":"10.25259\/Cytojournal_164_2025\/ref-3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.25259\/Cytojournal_164_2025\/ref-4","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1158\/0008-5472.CAN-21-2934","article-title":"Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma","volume":"82","author":"Mok","year":"2022","journal-title":"Cancer Res"},{"key":"10.25259\/Cytojournal_164_2025\/ref-5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcancer.2019.08.007","article-title":"SOX2 in development and cancer biology","volume":"67","author":"Novak","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.25259\/Cytojournal_164_2025\/ref-6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13046-020-01690-z","article-title":"TM4SF1 promotes EMT and cancer stemness via the Wnt\/nt\/the Wnt\/ the Wnt\/nd cancer stemness via t","volume":"39","author":"Tang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.25259\/Cytojournal_164_2025\/ref-7","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41388-022-02228-7","article-title":"SOX2 mediates metabolic reprogramming of prostate cancer cells","volume":"41","author":"De Wet","year":"2022","journal-title":"Oncogene"},{"key":"10.25259\/Cytojournal_164_2025\/ref-8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.devcel.2020.10.014","article-title":"Stromal SOX2 upregulation promotes tumorigenesis through the generation of a SFRP1\/2-expressing cancer-associated fibroblast population","volume":"56","author":"Kasashima","year":"2021","journal-title":"Dev Cell"},{"key":"10.25259\/Cytojournal_164_2025\/ref-9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10717544.2022.2057617","article-title":"Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3\/SOX2 axis","volume":"29","author":"Xie","year":"2022","journal-title":"Drug Deliv"},{"key":"10.25259\/Cytojournal_164_2025\/ref-10","doi-asserted-by":"publisher","first-page":"685912","DOI":"10.3389\/fonc.2021.685912","article-title":"Downregulation of SOX2-OT prevents hepatocellular carcinoma progression through miR-143-3p\/MSI2","volume":"11","author":"Zhao","year":"2021","journal-title":"Front Oncol"},{"key":"10.25259\/Cytojournal_164_2025\/ref-11","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1002\/ctm2.352","article-title":"AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation","volume":"11","author":"Bian","year":"2021","journal-title":"Clin Transl Med"},{"key":"10.25259\/Cytojournal_164_2025\/ref-12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.79876","article-title":"Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation","volume":"13","author":"Lu","year":"2023","journal-title":"Theranostics"},{"key":"10.25259\/Cytojournal_164_2025\/ref-13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: Regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.25259\/Cytojournal_164_2025\/ref-14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/13813455.2019.1675714","article-title":"The role of autophagy and mitophagy in cancers","volume":"128","author":"Xu","year":"2022","journal-title":"Arch Physiol Biochem"},{"key":"10.25259\/Cytojournal_164_2025\/ref-15","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1080\/15548627.2024.2358732","article-title":"TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy","volume":"20","author":"Zhang","year":"2024","journal-title":"Autophagy"},{"key":"10.25259\/Cytojournal_164_2025\/ref-16","doi-asserted-by":"publisher","first-page":"216621","DOI":"10.1016\/j.canlet.2024.216621","article-title":"Icaritin with autophagy\/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1\/ Parkin-mediated mitophagy in hepatocellular carcinoma","volume":"587","author":"Luo","year":"2024","journal-title":"Cancer Lett"},{"key":"10.25259\/Cytojournal_164_2025\/ref-17","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.3390\/cancers13194994","article-title":"The miR-27a\/FOXJ3 axis dysregulates mitochondrial homeostasis in colorectal cancer cells","volume":"13","author":"Barisciano","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.25259\/Cytojournal_164_2025\/ref-18","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.21873\/anticanres.16470","article-title":"FOXJ3 regulates cell proliferation and motility through modulating snail expression in breast cancer cells","volume":"43","author":"Seo","year":"2023","journal-title":"Anticancer Res"},{"key":"10.25259\/Cytojournal_164_2025\/ref-19","doi-asserted-by":"publisher","first-page":"819128","DOI":"10.3389\/fonc.2022.819128","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: Are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"10.25259\/Cytojournal_164_2025\/ref-20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.25259\/Cytojournal_118_2024","article-title":"Prominin 2 knockdown inhibits the growth, migration, and invasion of non-small cell lung cancer cells by repressing phosphatidylinositol 3 kinase\/ protein kinase B pathway","volume":"22","author":"He","year":"2025","journal-title":"Cytojournal"},{"key":"10.25259\/Cytojournal_164_2025\/ref-21","doi-asserted-by":"publisher","first-page":"103302","DOI":"10.1016\/j.redox.2024.103302","article-title":"FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production","volume":"75","author":"Sun","year":"2024","journal-title":"Redox Biol"},{"key":"10.25259\/Cytojournal_164_2025\/ref-22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.25259\/Cytojournal_164_2025\/ref-23","doi-asserted-by":"publisher","first-page":"114336","DOI":"10.1016\/j.biopha.2023.114336","article-title":"SOX2-associated signaling pathways regulate biological phenotypes of cancers","volume":"160","author":"Ding","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.25259\/Cytojournal_164_2025\/ref-24","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1158\/0008-5472.CAN-21-0567","article-title":"Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res"},{"key":"10.25259\/Cytojournal_164_2025\/ref-25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-021-03733-5","article-title":"SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by \u03b2-catenin and Beclin1\/autophagy signaling in colorectal cancer","volume":"12","author":"Zhu","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.25259\/Cytojournal_164_2025\/ref-26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/mc.23824","article-title":"microRNA-2117 negatively regulates liver cancer stem cells expansion and chemoresistance via targeting SOX2","volume":"64","author":"Xia","year":"2025","journal-title":"Mol Carcinog"},{"key":"10.25259\/Cytojournal_164_2025\/ref-27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.devcel.2021.02.010","article-title":"Autophagy and organelle homeostasis in cancer","volume":"56","author":"Miller","year":"2021","journal-title":"Dev Cell"},{"key":"10.25259\/Cytojournal_164_2025\/ref-28","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/ijms24032652","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.25259\/Cytojournal_164_2025\/ref-29","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist Updat"}],"container-title":["Cytojournal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cytojournal.com\/sox2-promotes-the-progression-of-hepatocellular-carcinoma-by-targeting-foxj3-and-activating-the-pi3k-akt-pathway-to-regulate-autophagy-and-mitophagy\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cytojournal.com\/sox2-promotes-the-progression-of-hepatocellular-carcinoma-by-targeting-foxj3-and-activating-the-pi3k-akt-pathway-to-regulate-autophagy-and-mitophagy\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:21:52Z","timestamp":1778847712000},"score":1,"resource":{"primary":{"URL":"https:\/\/cytojournal.com\/sox2-promotes-the-progression-of-hepatocellular-carcinoma-by-targeting-foxj3-and-activating-the-pi3k-akt-pathway-to-regulate-autophagy-and-mitophagy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":29,"alternative-id":["10.25259\/Cytojournal_164_2025"],"URL":"https:\/\/doi.org\/10.25259\/cytojournal_164_2025","relation":{},"ISSN":["1742-6413","0974-5963"],"issn-type":[{"value":"1742-6413","type":"electronic"},{"value":"0974-5963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"28"}}